APA Alıntı

Schmidt, E., Mustonen, T., Kiuru-Enari, S., Kivelä, T. T., & Atula, S. (2020). Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study. Orphanet J Rare Dis.

Chicago Stili Alıntı

Schmidt, Eeva-Kaisa, Tuuli Mustonen, Sari Kiuru-Enari, Tero T. Kivelä, ve Sari Atula. "Finnish Gelsolin Amyloidosis Causes Significant Disease Burden but Does Not Affect Survival: FIN-GAR Phase II Study." Orphanet J Rare Dis 2020.

MLA Alıntı

Schmidt, Eeva-Kaisa, et al. "Finnish Gelsolin Amyloidosis Causes Significant Disease Burden but Does Not Affect Survival: FIN-GAR Phase II Study." Orphanet J Rare Dis 2020.